Skip to content

Do men and women need different amouts of medication to suppress coughing after nose surgery?

Effective site concentration of remifentanil for smooth emergence through pain reduction of airway during extubation in male and female patients undergoing nasal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011248
Enrollment
40
Registered
2025-12-04
Start date
2018-12-03
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Intervention Name: Remifentanil TCI via Dixon's Up-and-Down Method Description: Continuous intravenous infusion of remifentanil is administered using a Target-Controlled Infusion (TCI) pump st

Sponsors

The Catholic University of Korea, St. Vincent's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients aged 19 to 65 years 2. Patients with American Society of Anesthesiologists (ASA) physical status I or II 3.Male and female patients scheduled for nasal surgery under general anesthesia

Exclusion criteria

Exclusion criteria: 1. Patients with a body mass index (BMI) = 30 kg/m² 2. Patients with a history or anticipation of a difficult airway 3. Patients with obstructive sleep apnea 4. Patients with recent respiratory infection, chronic respiratory disease, or chronic cough 5. Current smokers 6 Patients currently taking opioids, sedatives, antitussives, or angiotensin-converting enzyme (ACE) inhibitors

Design outcomes

Primary

MeasureTime frame
Effective effect-site concentration (EC50) of remifentanil for cough suppression

Secondary

MeasureTime frame
Recovery times; Time to eye opening and Time to extubation, ;Hemodynamic change( heart rate, blood pressure, saturation);Postanesthetic Complication (sedation, bradypnea and desaturation, nausea and vomitting)

Countries

Korea, Republic of

Contacts

Public ContactYeon Su Jeon

The Catholic University of Korea, St. Vincent's Hospital

like9497@naver.com+82-31-249-7271

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026